It's impossible to compare solid tumor ORR with liquid tumor ORR. I don't think that is valid comparison.
However, I do agree with your technology assessment of IMGN and SGEN in general. Based on the evidence, I have come to conclude SGEN's ADC seems to have wider applicability than IMGN's TAP.